AuramerBio is an aptamer development company specialising in the translation of aptamer science into analytical tools and diagnostic assays.
We are commercialising a number of aptamer sensing technologies and services. Coupling our aptamer design expertise with novel assays and devices, AuramerBio provides customisable sensing solutions for medical and environmental research and beyond. Our team is particularly proficient with small molecule targets, as illustrated by our growing catalogue of gold standard hormone binding aptamers. We work with a wide range of customers, both academic and commercial so please get in contact to explore how we can help you.
Our team have developed a portfolio of market leading small molecule binding aptamers. These are exemplified by our range of fertility hormone binding aptamers and assay platforms. Contact us for further information
Aptamer Development Service
Using our proprietary selection and optimisation methods we can produce industry leading DNA aptamers to bind the target of your choice. Once an aptamer has been developed we also offer a service to optimise its performance on a range of assay platforms.
We have a growing catalogue of DNA aptamers available to purchase for research and evaluation. If the target you are interested in is not shown please contact us as we have a number of other targets in development.
Estradiol (Kd 27.8 ± 10.7 nM)
Progesterone (Kd 64.5 ± 31.2 nM)
Testosterone (Kd 33.8 ± 14.5 nM)
Androstenedione (Kd 15.3 ± 6.5 nM)
Bisphenol A (BPA) (Kd 7.4 ± 2.6 nM)
All of our aptamers are available as AptaGold assay kits, please contact us for further information.
We are also developing a number of proprietary assay platforms including an electrochemical aptasensor capable of quantifying Estradiol at sub-femto grams per ml in biological samples (Urine and Blood).
Our team has a wide skill-base positioning us perfectly to rapidly deploy aptamers into a range analytical assay and device platforms.
Jeremy has over 10 years of experience working in the Biotechnology industry commercialising hi-tech intellectual property. He leads the AuramerBio team and our commercialisation activities.
Dr Shalen Kumar
Shalen is a SELEX expert and a founding inventor of our technology platform, he leads the technical team and is responsible for aptamer development services delivery.
Dr Justin Hodgkiss
Justin is a founding inventor of our electrochemical platform and manages this R&D program. He is also deputy director of the MacDiarmid Institute which provides science support to AuramerBio.
Professor Ken McNatty
Ken is a reproductive science guru and is responsible for our team’s interest in aptamers over 10 years ago. He is a founding inventor and provides a wealth of expertise and mentorship to the team.
Professor David Williams
David brings commercial assay development expertise to the team this includes a wealth of experience with lateral flow techniques amongst others. With a publication record of over 200 papers and 40 patents his experience is invaluable to the team.
For further information about any of our products or services please get in contact as we would be delighted to discuss how we can help.
Call us on +64 21 834 284 or send us a message